Successful start of the Drug Development Network "NetPhaSol"
The Network for Pharma Solutions - NetPhaSol, launched in May 2017, is a cooperation network focussing on drug discovery & development. It serves as a platform for research, development and marketing of new products, processes and services in drug development. The primary focus are the first value chain stages of a drug development cycle - however, further development stages are not excluded.
The network offers an attractive performance portfolio in the fields of e.g. drug discovery, target validation, lead optimization and preclinical development to potential customers, partners and investors for participation and cooperation. The portfolio does not only represent the development of its own products and services and their marketing, but should also be attractive to potential customers of contract research or development.
The initiative will present its portfolio at BioEurope in Berlin (Nov 6th-8th). NetPhaSol is a German network of 47 partners (currently 27 companies and 20 scientific institutions). New project partners (also from outside of Germany) are cordially invitated to participate. They will be supported in a targeted way in order
- Submit promising applications for R&D projects
- Develop new products and technologies in joint projects
- Join forces in marketing and distribution
- Gain more market power and visibility
- Provide joint services and products for pharmaceutical industry
Please contact the network management for further questions. We look forward to receiving your inquiries!
• Volker Erb (volker.erb(at)berlin-partner.de; 030 46302 515)
• Dr. Jasmin Podufall (jasmin.podufall(at)berlin-partner.de; 030 46302 542)
NetPhaSol has been funded by the Federal Ministry of Economics and Energy since May 2017 as part of the program "Zentrales Innovationsprogramm Mittelstand (ZIM)". Berlin Partner for Business and Technology, Unit Biotech / Pharma, has initiated and accompanied network formation and is in charge of the network management.